Crawford Investment Counsel Inc Amgen Inc Transaction History

Crawford Investment Counsel Inc

$5.7 Billion
Q3 2024

A detailed history of Crawford Investment Counsel Inc transactions in Amgen Inc stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 7,705 shares of AMGN stock, worth $2.04 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,705

Previous 7,605 1.31%

Holding current value

$2.04 Million

Previous $2.38 Million 4.46%

% of portfolio

0.04%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $30,938 - $33,738	100 Added 1.31%	7,705 $2.48 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $57,542 - $69,928	-219 Reduced 2.8%	7,605 $2.38 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $57,807 - $69,780	215 Added 2.83%	7,824 $2.22 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $3,835 - $4,326	15 Added 0.2%	7,609 $2.19 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $2,257 - $2,752	-10 Reduced 0.13%	7,594 $1.84 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $64,357 - $81,773	281 Added 3.84%	7,604 $2 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $8,753 - $9,872	-39 Reduced 0.53%	7,323 $1.65 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $24,916 - $27,727	-108 Reduced 1.45%	7,362 $1.79 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $44,950 - $49,726	205 Added 2.82%	7,470 $1.81 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $4,375 - $5,007	-22 Reduced 0.3%	7,265 $1.63 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $4,669 - $5,471	22 Added 0.3%	7,287 $1.55 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $20,772 - $24,736	96 Added 1.34%	7,265 $1.67 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $8,447 - $9,394	36 Added 0.5%	7,169 $1.82 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $23,143 - $28,400	-117 Reduced 1.61%	7,133 $1.68 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $8,357 - $10,013	48 Added 0.67%	7,250 $1.4 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $3,500 - $4,103	-21 Reduced 0.29%	7,202 $1.33 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $48,175 - $54,311	-260 Reduced 3.47%	7,223 $1.5 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $63,763 - $71,619	384 Added 5.41%	7,483 $1.38 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $16,604 - $19,404	98 Added 1.4%	7,099 $1.21 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $24,643 - $27,534	146 Added 2.13%	7,001 $1.22 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.15 Million - $1.31 Million	6,855	6,855 $1.28 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Investment Counsel Inc with notifications on news.

Account

Crawford Investment Counsel Inc Amgen Inc Transaction History